Stinging insect allergy

Allergology International

Volumn 47, Issue 4, 1998, Pages 247-254

  Reisman, Robert E ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Buffalo Medical Group   (United States)

Author keywords

Clinical reactions; Diagnosis; Immunotherapy; Natural history; Venom allergy

Indexed keywords

ADRENALIN; IMMUNOGLOBULIN G; VENOM;

ALLERGIC REACTION; ANAPHYLAXIS; ANTIGEN SPECIFICITY; HUMAN; IMMUNOTHERAPY; INSECT ALLERGY; INSECT STING; LIFESTYLE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SKIN TEST; TREATMENT FAILURE;

EID: 0032440474     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1592.1998.00101.x     Document Type: Review

References (37)

1. Mauriello PM, Barde SH, Georgitis JW, Reisman RE Natural history of large location reactions from stinging insects, J. Allergy Clin. Immunol. 1984; 74: 494-8.
2. McKenna WR Killer bees: What the allergist should know. Pediatr. Asthma Allergy Immunol. 1992; 4: 275-85.
3. Chaffee FH. The prevalence of bee sting allergy in an allergic population. Acta Allergol. 1970; 25: 292-3.
4. Settipane GA, Boyd GK. Prevalence of bee sting allergy in 4,992 Boy Scouts. Acta Allergol. 1970; 25: 286-97.
5. Golden DBK. Epidemiology of allergy to insect venoms and stings. Allergy Proc. 1989; 10: 103-7.
6. Lantner R, Reisman RE Clinical and immunologic features and subsequent course of patients with severe insect sting anaphylaxis. J. Allergy Clin. Immunol. 1989; 84: 900-6.
7. Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J. Allergy Clin. Immunol. 1973; 52: 259-64.
8. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N. Engl. J. Med. 1978; 299: 157-61.
9. Valentine MD, Sohuberth KC, Kagey-Sobotka A et al. The value of immunotherapy with venom in children with allergy to insect stings. N. Engl. J. Med. 1991; 23: 1601-3.
10. Reisman RE Natural history of insect sting allergy: Relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions. J. Allergy Clin. Immunol. 1992; 90: 335-9.
11. Reisman RE, Livingston A. Late onset reactions including serum sickness, following insect stings, J. Allergy Clin. Immunol. 1989; 84: 331-7.
12. Hunt KJ, Valentine MD, Sobotka AK, Lichtenstein LM. Diagnosis of allergy to stinging insects by skin testing with Hymenoptera venoms. Ann. Intern. Med. 1976; 85: 56-9.
13. Georgitis JW, Reisman FE Venom skin tests in insect-allergic and insect non-allergic populations J. Allergy Clin. Immunol. 1985; 76: 803-7.
14. Light WC, Reisman RE, Wypych JI, Arbesman CE Clinical and immunological studies of beekeepers. Clin. Allergy 1975; 5: 389-95.
15. Lessof MH, Sbbotka AK, Liechtenstein LM. Effects of passive antibody in bee venom anaphylaxis. Johns Hopkins Med. J 1978; 142: 1-7.
16. Schumacher MJ, Tveten MS, Egen NB. Rate and quantity of delivery of venom from honeybee stings, J. Allergy Clin. Immunol. 1994; 93: 831-5.
17. Valentine MD. Insect venom allergy: Diagnosis and treatment, J. Allergy Clin. Immunol. 1984; 73: 299-304.
18. Reisman RE, Livingston A. Venom immunotherapy: 10 years of experience with administration of single venoms and 50 μg maintenance doses, J. Allergy Clin. Immunol. 1992; 89: 1189-95.
19. van der Linden PWG, Hack CE, Poortman J et al. Insect sting challenge in 138 patients: Relation between clinical severity of anaphylaxis and mast cell activation, J. Allergy Clin. Immunol. 1992; 90: 110-18.
20. Lichtenstein LM. A reappraisal of sting challenges: To whom should we offer venom immunotherapy? J. Allergy Clin. Immunol. 1994; 94: 137-8.
21. Franken HH, DuBois AEJ, Minkema HJ, van der Heide S, de Monchy JGR Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity J. Allergy Clin. Immunol. 1994; 93: 431-5.
22. Smith PL, Kagey-Sobotka A, Bleecker ER et al. Physiologic manifestations of human anaphylaxis. J. Clin. Invest. 1980; 66: 1072-80.
23. Mueller U, Elliott WB, Reisman RE et al. Comparison of the biochemical and immunologic properties of venoms from the four hornet species, J. Allergy Clin. Immunol. 1981; 67: 290-8.
24. Reisman RE, Mueller U, Wypych JI, Elliott WB, Arbesman CE Comparison of the allergenicity and antigenicity of yellow jacket and hornet venoms, J. Allergy Clin. Immunol. 1982; 69: 268-74.
25. Reisman RE, Wypych JI, Mueller UR, Grant JA. Comparison of the allergenicity and antigenicity of Polistes venom and other vespid venoms. J. Allergy Clin. Immunol. 1982; 70: 281-7.
26. Reisman RE, Mueller UR, Wypych JI, Lazell MI. Studies of coexisting honeybee venom and vespid venom sensitivity J. Allergy Clin. Immunol. 1984; 73: 246-52.
27. Golden DBK, Kagey-Sobokta A, Valentine MD, Lichtenstein LM. Prolonged maintenance interval in Hymenoptera venom immunotherapy. J. Allergy Clin. Immunol. 1981; 67: 482-4.
28. Goldberg A, Reisman RE Prolonged interval maintenance venom immunotherapy Ann. Allergy 1988; 61: 177-9.
29. Reisman RE Late-onset reactions following venom immunotherapy and venom skin tests. Ann. Allergy 1988; 61: 383-7.
30. Schwartz HJ, Golden DBK, Lockey RE Venom immuno-therapy in the Hymenoptera allergic pregnant patient. J. Allergy Clin. Immunol. 1990; 85: 709-12.
31. Golden DBK, Lawrence ID, Hamilton RH et al. Clinical correlations of the venom specific IgG antibody level during maintenance venom immunotherapy J. Allergy Clin. Immunol. 1992; 90: 386-93.
32. Reisman RE Should routine measurements of serum venom specified IgG be a standard of practice in patients receiving venom immunotherapy? J. Allergy Clin. Immunol. 1992; 90: 282-4.
33. American Academy of Allergy Asthma and Immunology Position Statement. Report from the Committee on Insects. J. Allergy Clin. Immunol. 1998; 101: 573-5.
34. Golden DBK, Kwiterovich KA, Kagey-Sobotka A, Lichtenstein LM. Discontinuing venom immunotherapy: Extended observations, J. Allergy Clin. Immunol. 1998; 101: 298-305.
35. Lerch E, Muller UR Long-term protection after stopping venom immunotherapy; Results of re-stings in 200 patients. J. Allergy Clin. Immunol. 1998; 101: 606-12.
36. van Halteren HK, van der Linden PWG, Burgers JA, Bartelink AKM. Discontinuation of yellow jacket venom immunotherapy. Follow up of 75 patients by means of deli berate sting challenge, J. Allergy Clin. Immunol. 1997; 100: 767-70.
37. Reisman RE Duration of venom immunotherapy; relationship to the severity of symptoms of initial sting anaphylaxia. J. Allergy Clin. Immunol. 1993; 92: 831-6.